Company profile
Ligence Uab
Ligence Uab has 2 AI-enabled medical devices on the FDA list. The first decision was on September 26, 2025 and the most recent on February 27, 2026 (Ligence Heart). Its most common review panel is Radiology (2 devices).
2AI devices
2025First decision
2026Latest decision
1Specialties